"Biden's Cancer Moonshot: $24M Investment in mRNA Tech to Strengthen Immune System and Save Lives"
The Biden Cancer Moonshot has launched the CUREIT project, led by Emory University, to develop mRNA platforms that can train the immune system to fight cancer and other diseases. With up to $24 million in funding from ARPA-H, the project aims to create a toolbox of mRNA technologies that can enhance immune responses, potentially revolutionizing the fight against cancer and other difficult diseases. This is the first award from ARPA-H's Open Broad Agency Announcement, with future projects to be funded on a rolling basis.